Global Ophthalmic Anti-VEGF Therapeutics Market Size, Share, and COVID-19 Impact Analysis, By Drug Type (Biologics and Biosimilars), By Indication (Age-related macular degeneration, Diabetic retinopathy, Macular edema, Retinal vein occlusion, and Myopic choroidal neovascularization), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and
Premium Report Details
Base Year:
2024
Tables & Figures:
110
Pages:
198
Countries covered:
17
Companies covered::
20
Forecast CAGR:
5.09%
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies